Advertisement Female Health Company to expand manufacturing capacity for FC2 Female Condom - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Female Health Company to expand manufacturing capacity for FC2 Female Condom

The Female Health Company, a manufacturer of female condoms, has said that it plans to install six more production lines for its FC2 Female Condom, increasing its annualized FC2 production capacity in Malaysia from 30 million units to approximately 75-80 million units.

Currently, The Female Health Company (FHC) is manufacturing its second-generation product, FC2, on four production lines in Malaysia. The company, in conjunction with its Indian partner, HLL Lifecare, currently produces FC2 on a fifth production line located in Kochi, India.

The approval by FDA permits sale of FC2 in the US and purchases by the US Agency for International Development for distribution in HIV/AIDS prevention programs throughout the world.

Mike Pope, vice president of UK and Malaysian operations, said: “The Malaysian production expansion will bring the total FC2 female condom manufacturing capacity to an annualized rate of approximately 85 million units by early in the fourth quarter of calendar year 2009.”